Activities of Daily Living and Upper Extremity Exercise Capacity of Individuals with High Body Mass Index
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorKirsehir Ahi Evran Universitesi
About this trial
Individuals with high and normal body mass index will be included in this study.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Body mass index ≥ 25 kg/m2
Volunteering for the study
Disqualifiers
Having uncontrolled hypertension, diabetes mellitus
Having comorbidities that may affect physical functions
Failure to cooperate with tests to be performed
Liver disease, kidney disease, cancer, lung diseases and serious cardiomyopathies, neurological diseases
Trial population
Individuals with high and normal body mass index will be included in the study.
Trial design
Design model
Case-control
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
24 Participants
are grouped into 2 trial groupsGroup A: Individuals with high body mass index
Group B: Individuals with normal body mass index
Trial outcomes
Primary outcomes
1
Upper extremity exercise capacity
It will be assessed by 6 minute pegboard and ring test.
Time frame
1st day2
Daily living activities
It will be evaluated with the Glittre activities of daily living test.
Time frame
1st daySecondary outcomes
1
Fatigue
Fatigue will be assessed with a Fatigue Severity scale. The scale consists of 9 questions.The total score ranges from 9 to 63. An average score of 4 and above indicates severe fatigue.
Time frame
1st day2
Pain
It will be evaluated with the Nordic Musculoskeletal Questionnaire. It consists of 27 items that assess the presence of musculoskeletal symptoms over a 12-month period, covering nine different parts of the body. There are also items on functional status and the presence of musculoskeletal symptoms in the last 7 days. The total number of painful areas is determined. Total number of painful areas varies from 0-9.
Time frame
1st daySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov